HTB supplement with a focus on southern Africa produced and distributed in partnership with the Southern African HIV Clinicians’ Society.
About HTB South
Editor: Polly Clayden. Contributing editor: Simon Collins. ISSN 2046-9373.
Subscribe
Subscriptions are free.
Medical review board
Each issue of HTB South is circulated for comments to our medical review board.
Recent arcticles
- South Africans are living longer: antiretroviral treatment vindicated 21 April 2013.
- RIFAQUIN trial proves new TB regimen 18 March 2013.
- Volume 5 Number 4 October/December 2012 PDF 1 November 2012.
- Volume 5 Number 4 October/December 2012 1 November 2012.
- 52nd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 9-12 September 2012, San Francisco 1 November 2012.
- Study summaries from ICAAC 2012 1 November 2012.
- Antiviral activity in vitro with S/GSK1265744 1 November 2012.
- Efavirenz interaction studies with TB compounds bedaquiline and delamanid 1 November 2012.
- 19th IAS World AIDS Conference, 22–25 July 2012, Washington 1 November 2012.
- HPTN-052: clinical advantages from earlier treatment 1 November 2012.
- Hormonal contraception and the risk of HIV acquisition 1 November 2012.
- Towards an HIV cure: Early developments reported at IAS, part 2 1 November 2012.
- Online video interviews between researchers and activists 1 November 2012.
- FDA approves Quad in US: price may prohibit UK access 1 November 2012.
- Merck acquires CMX157 and EFdA and starts phase 2 study for new NNRTI 1 November 2012.
- FDA approval of generic ARVs 1 November 2012.
- Free HIV treatment in the UK for all, irrespective of residency status 1 November 2012.
- Robin Hood Tax begins in France 1 November 2012.
- Novartis case enters Indian Supreme court 1 November 2012.
- India: Bayer stay order against compulsory licence denied 1 November 2012.